About Amwell Biotech Private Limited
Data last updated:
Amwell Biotech Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the online healthcare product retail segment of the e-commerce sector. It was incorporated on 13 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U52609TN2019PTC131055. Its GSTIN is 33AASCA6160C1ZU (Tamil Nadu).
The company has an authorised share capital of ₹35 Lakh and a paid-up capital of ₹32.5 Lakh. It is led by directors including Shiv Kumar Jindal (Managing Director) and Puthiya Purayil Abdul Sathar.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at No.5C Kilpauk Garden Road 1st Street Kilpauk, Chennai, Tamil Nadu, India – 600010.
As per the financials filed for FY 2023, the company reported a revenue of ₹27.63 Lakh, a growth of 93% compared to the previous year. For the same year it recorded a net loss of ₹16.04 Lakh (net margin -58.1%) and EBITDA of -₹15.22 Lakh (EBITDA margin -55.1%).
The company has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹22.5 Lakh; the latest was in May 2021.
For more details, the company can be reached via its website amwelltechnology.com.
Company details
Contact details
Amwell Biotech Private Limited's registered office is in Chennai, Tamil Nadu.
- Registered AddressNo.5C Kilpauk Garden Road 1st Street Kilpauk, Chennai, Tamil Nadu, India – 600010
- IndustryE-Commerce, Online Healthcare Product Retail
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Amwell Biotech is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Amwell Biotech Private Limited, buy the company report.
Financials of Amwell Biotech Private Limited
FY 2023 filings availableAmwell Biotech Private Limited reported revenue of ₹27.63 Lakh (up 93% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 93% in the latest year. EBITDA rose 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹15.22 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹16.04 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -55.1% | |||
| Net Profit Margin | -58.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Amwell Biotech Private Limited, buy the company report.
Board of directors of Amwell Biotech Private Limited
Amwell Biotech has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Puthiya Purayil Abdul Sathar | Director | 01 Jul 2021 | 5 Years 4 Months | Current |
| Chinthla Shyam Sundar | Director | 13 Aug 2019 | 7 Years 2 Months | Current |
| Shiv Kumar Jindal | Managing Director | 30 Sep 2023 | 3 Years 1 Months | Current |
Deals & funding
Amwell Biotech Private Limited has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹22.5 Lakh; the latest was in May 2021.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2021 | Funding round | ₹22.5 Lakh | Investors: 2 individuals |
| Dec 2019 | Rights issue | ₹8.5 Lakh | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Amwell Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Amwell Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Amwell Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AASCA6160C1ZU | Tamil Nadu | Active | 05 Nov 2019 |
To see the full GST registrations and return filing status of Amwell Biotech Private Limited, buy the company report.
Recent activity
Amwell Biotech Private Limited has 6 board changes on record since 2019: 3 appointments and 3 cessations. The latest: Shiv Kumar Jindal was appointed as Managing Director on 30 Sep 2023.
Frequently asked questions
Amwell Biotech is an active private limited company based in Chennai, Tamil Nadu, India. The company works in online healthcare product retail, within the e-commerce industry. It was incorporated on 13 August 2019 (7+ years old) and is registered under CIN U52609TN2019PTC131055.
Amwell Biotech has 3 current directors:
- Shiv Kumar Jindal - Managing Director
- Puthiya Purayil Abdul Sathar - Director
- Chinthla Shyam Sundar - Director
The latest financial statements of Amwell Biotech on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Amwell Biotech is 33AASCA6160C1ZU, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Amwell Biotech is U52609TN2019PTC131055. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amwell Biotech was incorporated on 13 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chennai.
Amwell Biotech has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹22.5 Lakh; the latest was in May 2021.
Shiv Kumar Jindal was appointed as Managing Director on 30 Sep 2023. Honey ceased to be Managing Director on 28 Nov 2022. Shiv Kumar Jindal ceased to be Additional Director on 28 Nov 2022. Amwell Biotech has 6 board changes on record in total.
Amwell Biotech can be reached through the website amwelltechnology.com. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Amwell Biotech is at No.5C Kilpauk Garden Road 1st Street Kilpauk, Chennai, Tamil Nadu, India – 600010.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
